Interview: Albin Egger – Country Representative, UCB Pharma Austria
Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian…
Address: Dresdner Straße 82
1200 Wien ,Austria
Tel: 01/331 07-0
Web: http://www.lundbeck.com/at
Lundbeck is an international pharmaceutical company highly committed to improving the quality of life for people suffering from brain disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disorders such as depression and anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and Parkinson’s diseases.
Lundbeck markets a number of different pharmaceuticals for the treatment of brain disorders. The most recently launched compounds include: Cipralex/Lexapro® (depression), Ebixa® (Alzheimer’s disease), Azilect® (Parkinson’s disease), Xenazine® (chorea associated with Huntington’s disease), Sabril® (epilepsy), Sycrest® (bipolar disorder) and OnfiTM (Lennox-Gastaut syndrome).
Albin Egger, country representative of UCB Pharma Austria, discusses the strong performance of the Austrian…
Joy Ladurner, co-director of the NKSE (National Coordination Center for Rare Diseases) in Austria, discusses the…
Alexander Biach, chairman of the Main Association of Austrian Social Security Institutions, discusses handling the…
Gerhard Hirczi of the Vienna Business Agency and Peter Halwachs of LISAvienna describe Vienna’s impressive…
Peter Wimmer, country manager of Angelini Austria and Germany, discusses the tailored long-term strategy that this…
Christoph Wahl and Gerlad Weirowski of DHL Global Forwarding Austria discuss the significance of the Austrian…
Christoph Sauermann, managing director of Mediclass, an innovative healthcare center, discusses how the…
Rudolf Widmann, CEO and founder of AOP Orphan, the first rare disease-specific European company, discusses the…
Barbara Rangetiner and Josef Weinberger of the Austrian affiliate of Octapharma, the largest privately owned human…
Dr. Wolfgang Harrer, regional manager of Chiesi Central and Eastern Europe (CEE), discusses the challenges of…
David Kasper, CEO of ARCHIMEDlife, an innovative Austrian company focused on novel laboratory diagnostics,…
Dr. Wolfgang Schnitzel, general manager of Shire Austria, and Karl-Heinz Hofbauer, site lead Vienna and managing…